RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA
Clinical trials for RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat lymphoma
Disease control Recruiting nowThis study tests two experimental drugs, SHR-0302 and SHR-2554, in about 25 people with a rare type of blood cancer (peripheral T-cell lymphoma) that has returned or not responded to prior therapy. The goal is to see if the combination can shrink or control the cancer. Participan…
Matched conditions: RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 17, 2026 05:29 UTC
-
New hope for rare blood cancer: phase 3 trial of XNW5004 launches
Disease control Recruiting nowThis study tests a new drug, XNW5004, against an existing treatment (Chidamide) for people with a rare blood cancer called peripheral T-cell lymphoma that has come back or not responded to prior therapy. About 120 adults aged 18-70 will participate. The main goal is to see if XNW…
Matched conditions: RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA
Phase: PHASE3 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
Promising combo tackles Hard-to-Treat lymphoma
Disease control Recruiting nowThis study tests whether a combination of three drugs (an anti-PD-1 antibody, lenalidomide, and azacitidine) can shrink tumors or stop them from growing in people with peripheral T-cell lymphoma that has come back or not responded to prior treatments. About 31 participants will r…
Matched conditions: RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 06, 2026 16:01 UTC